{"id":230259,"date":"2026-09-04T11:47:31","date_gmt":"2026-09-04T06:17:31","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=230259"},"modified":"2026-09-04T11:47:33","modified_gmt":"2026-09-04T06:17:33","slug":"is-global-health-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-global-health-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Global Health a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"
<\/div>\n

Global Health share price around Rs 1,520. 1.5% below 52-week high of Rs 1,544. Q1 FY27 revenue Rs 1,304 crore, up 26.5% YoY. PAT Rs 157 crore, down 1.1%. PE 74x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Global Health’s Q1 FY27 results were mixed, with revenue at Rs 1,304 crore but PAT falling 1% to Rs 157 crore. The Global Health share price near Rs 1,520 has not escaped this pressure, and the profit decline is the key data point investors should weigh before deciding whether Global Health is a good buy right now.<\/p>\n<\/div>\n

The Global Health share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Global Health is the operator of Medanta hospitals, a multi-specialty tertiary healthcare provider expanding its network including a new Noida facility, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 1,304 crore, up 26.5% year on year, while profit after tax came in at Rs 157 crore, down 1.1% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Global Health share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Global Health share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n